We are international
Donate
TEXT SIZE   


International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Martin - Results of PX-171-003-A1, an open-label, single-arm, phase (PH) 2 study of carfilzomib (CFZ) in patients (pts) with relapsed/refractory Multiple Myeloma (R/R MM)
Thomas Martin, MD
University of California, San Francisco
San Francisco, California USA
May 3-6, 2011
Paris, France
05.06.11
 related articles